Accelerating ADC Discovery and Development with Novel Payload-Linker and Conjugation Technologies

In this GEN webinar Jiawei Lu, PhD, Head of Bioconjugation Discovery Service at WuXiXDC, will discuss strategies for accelerating ADC discovery and development using novel payload linkers and conjugation technologies.

Maximizing Manufacturing Productivity with a Continuous Chromatography Process

REGISTER NOW Broadcast Date:  Thursday, June 27, 2024Time:  8:00 am PT, 11:00 am ET, 17:00 CEST Biologics manufacturers are under increasing pressure to reduce production costs....

Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers

In this GEN webinar, our expert speaker Oliver Höcker, PhD, will discuss the advantages and limitations of current analytical techniques for determining the CQAs of NA therapeutics using examples from different NA classes.

Customized mRNA Processing for Improved Therapy Development and Manufacturing

In TODAY's GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.

How Labs Can Prepare for AI-Based Protein Design and Engineering

In Tuesday's timely GEN webinar, Stef van Grieken and Prem Mohanty will discuss how the success of AI / ML technologies is tied to data quality and share specific approaches for generating clean lab data to train models faster.

Unveiling the Potential of Digital Intelligence to Empower Pharmaceutical Companies

In this GEN webinar, Storyful CEO Maria Pacheco will showcase several real-time examples that illustrate how access to digital intelligence can be timely, impactful, and agile for marketing communications strategy or PR in the pharmaceutical industry.

Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays

In this GEN webinar, our speaker John Renger, PhD, CSO at Cerevel Therapeutics, discusses preclinical markers used in assays relevant to neurodegenerative disease processes, including the evaluation of autophagy and mitophagy using methods such as immunohistochemistry, western blotting, ELISA-like assays, high content analysis, and other platforms.

Biologics Drug Development Gets an Upgrade with Humanized Animal Models

In this GEN webinar, Aaron Rose, PhD, explores how biological therapeutics are reshaping the traditional drug development process and why humanized models are essential for advancing biologics programs.

Fireside Chat: Post-AACR Spatial Biology Trends & Decoding Cancer Insights

Join this keynote discussion on the latest advancements, new norms, emerging trends and breakthrough topics from AACR by our expert panelists, offering clarity on the current landscape, with a deep dive into the latest advancements on how spatial biology is shaping precision medicine and cancer research. Hear expert perspectives on how the global research community has united in an unprecedented collaboration.

Rapid Clone Screening of Biosimilar Candidates Using Microfluidic CE-MS

In THIs GEN webinar, our expert speakers, Erin Redman, PhD, and Ruben Cageling, will describe how the ZipChip microfluidic CE-MS technology enables rapid early-stage clone screening for biotherapeutics development.

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

In this GEN webinar, two experts, Prashant Vaidyanathan, PhD, and Rob Brown, PhD, will discuss advancements in configurable lab workflows, AI ChatGPT, and next-generation lab informatics that are enabling novel discoveries in cell and gene therapy.

Detecting Growing Tumors through Changes in the Plasma Proteome

On this GEN webinar, SomaLogic CSO Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier.

Can Organoids Unlock the Pathology of Traumatic Brain Injuries?

In this GEN webinar, Justin Ichida, PhD, an expert in stem cell biology and regenerative medicine at the Keck School of Medicine, USC discusses using organoids to clear up the causes of neuronal damage following TBIs and ways of mitigating injury risks.

dPCR vs. qPCR: Selecting the Right Tool for Molecular Analysis

In this GEN webinar, our panelists Jim Huggett, PhD, and Boshen Gao will introduce the dPCR workflow and discuss this technology’s advantages over traditional qPCR including higher precision, more flexibility, increased sensitivity, and true absolute quantification.

Using AI-Based Spatial Analysis to Explore Immunotherapy Biomarkers

In this GEN webinar, our speakers Ettai Markovits, MD, and Arutha Kulasinghe, PhD, will discuss how AI-based spatial analysis of mIF data can accelerate the discovery of clinically relevant biomarkers that can predict response and resistance mechanisms to immunotherapy.